- Home
- GBIO vs HWH Comparison
GBIO vs HWH Comparison
Compare GBIO & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- HWH
- Stock Information
- Founded
- GBIO 2016
- HWH 2021
- Country
- GBIO United States
- HWH United States
- Employees
- GBIO N/A
- HWH N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- HWH Other Pharmaceuticals
- Sector
- GBIO Health Care
- HWH Health Care
- Exchange
- GBIO Nasdaq
- HWH Nasdaq
- Market Cap
- GBIO 23.2M
- HWH 21.2M
- IPO Year
- GBIO 2020
- HWH N/A
- Fundamental
- Price
- GBIO $0.39
- HWH $1.05
- Analyst Decision
- GBIO Strong Buy
- HWH
- Analyst Count
- GBIO 4
- HWH 0
- Target Price
- GBIO $7.33
- HWH N/A
- AVG Volume (30 Days)
- GBIO 559.5K
- HWH 595.4K
- Earning Date
- GBIO 05-12-2025
- HWH 05-14-2025
- Dividend Yield
- GBIO N/A
- HWH N/A
- EPS Growth
- GBIO N/A
- HWH N/A
- EPS
- GBIO N/A
- HWH N/A
- Revenue
- GBIO $19,892,000.00
- HWH $1,253,577.00
- Revenue This Year
- GBIO N/A
- HWH N/A
- Revenue Next Year
- GBIO $10.90
- HWH N/A
- P/E Ratio
- GBIO N/A
- HWH N/A
- Revenue Growth
- GBIO 236.92
- HWH 50.94
- 52 Week Low
- GBIO $0.32
- HWH $0.90
- 52 Week High
- GBIO $4.34
- HWH $15.75
- Technical
- Relative Strength Index (RSI)
- GBIO 43.58
- HWH 38.27
- Support Level
- GBIO $0.34
- HWH $1.01
- Resistance Level
- GBIO $0.40
- HWH $1.19
- Average True Range (ATR)
- GBIO 0.05
- HWH 0.12
- MACD
- GBIO 0.01
- HWH 0.01
- Stochastic Oscillator
- GBIO 61.29
- HWH 35.71
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About HWH HWH International Inc.
HWH International Inc is a purpose-driven lifestyle company enabling home-based people in the new GIG economy to create lasting wealth. Developing new pathways in the aid of helping people in their pursuit of Health, Wealth and Happiness.